AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Return 0.94%
This Quarter Return
+3.56%
1 Year Return
+0.94%
3 Year Return
+28.58%
5 Year Return
+40.76%
10 Year Return
AUM
$307M
AUM Growth
+$20.4M
Cap. Flow
+$10.8M
Cap. Flow %
3.52%
Top 10 Hldgs %
29.82%
Holding
1,175
New
79
Increased
283
Reduced
241
Closed
135
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ON icon
676
ON Semiconductor
ON
$19.9B
$11K ﹤0.01%
600
OUT icon
677
Outfront Media
OUT
$3.17B
$11K ﹤0.01%
432
SU icon
678
Suncor Energy
SU
$49.7B
$11K ﹤0.01%
+312
New +$11K
SRCL
679
DELISTED
Stericycle Inc
SRCL
$11K ﹤0.01%
150
RRD
680
DELISTED
RR Donnelley & Sons Co.
RRD
$11K ﹤0.01%
+1,025
New +$11K
GXP
681
DELISTED
Great Plains Energy Incorporated
GXP
$11K ﹤0.01%
375
-200
-35% -$5.87K
POT
682
DELISTED
Potash Corp Of Saskatchewan
POT
$11K ﹤0.01%
558
+158
+40% +$3.12K
AGU
683
DELISTED
Agrium
AGU
$11K ﹤0.01%
100
AER icon
684
AerCap
AER
$21.9B
$10K ﹤0.01%
200
AHH
685
Armada Hoffler Properties
AHH
$587M
$10K ﹤0.01%
+733
New +$10K
FDIS icon
686
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.89B
$10K ﹤0.01%
287
IWR icon
687
iShares Russell Mid-Cap ETF
IWR
$44.5B
$10K ﹤0.01%
212
LIT icon
688
Global X Lithium & Battery Tech ETF
LIT
$1.14B
$10K ﹤0.01%
+260
New +$10K
NBIX icon
689
Neurocrine Biosciences
NBIX
$14.3B
$10K ﹤0.01%
170
NVCR icon
690
NovoCure
NVCR
$1.42B
$10K ﹤0.01%
+500
New +$10K
PBE icon
691
Invesco Biotechnology & Genome ETF
PBE
$226M
$10K ﹤0.01%
200
PDSB icon
692
PDS Biotechnology
PDSB
$55M
$10K ﹤0.01%
45
REGN icon
693
Regeneron Pharmaceuticals
REGN
$59B
$10K ﹤0.01%
22
RNR icon
694
RenaissanceRe
RNR
$11.3B
$10K ﹤0.01%
100
RXI icon
695
iShares Global Consumer Discretionary ETF
RXI
$273M
$10K ﹤0.01%
+100
New +$10K
STWD icon
696
Starwood Property Trust
STWD
$7.53B
$10K ﹤0.01%
450
-500
-53% -$11.1K
WPC icon
697
W.P. Carey
WPC
$14.7B
$10K ﹤0.01%
150
VTNR
698
DELISTED
Vertex Energy, Inc
VTNR
$10K ﹤0.01%
12,803
NTUS
699
DELISTED
Natus Medical Inc
NTUS
$10K ﹤0.01%
274
FLXN
700
DELISTED
Flexion Therapeutics, Inc.
FLXN
$10K ﹤0.01%
400